LABELED FACTOR-IX KINETICS IN PATIENTS WITH HEMOPHILIA-B
- 1 January 1981
- journal article
- research article
- Vol. 58 (3) , 625-629
Abstract
Labeled factor IX was infused 5 times into 4 patients with hemophilia B. Ten-minute plasma recovery averaged 35% (SD .+-. 2) and the mean T1/2 .beta.-phase [plasma half-life] elimination was 23 h (.+-. 5). No alteration in the postinfusion 125I-factor-IX could be detected by radioautography of plasma samples run on polyacrylamide gels or on crossed-immunoelectrophoresis. Label was excreted into the urine as free 125l-iodide. Kinetics were similar when the labeled preparation was infused alone or with a commerical concentrate containing unlabeled factor IX. Infusion of factor IX in man is best described by a 2-compartment open pharmacokinetic model where factor IX is distributed in a space larger than the plasma volume.This publication has 4 references indexed in Scilit:
- Human Factor IX in Animals: Kinetics from Isolated, Radiolabelled Protein and Platelet Destruction following Crude Concentrate InfusionsBritish Journal of Haematology, 1980
- Human plasma P component: isolation and characterizationBiochemistry, 1978
- Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.Journal of Clinical Investigation, 1978
- Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.Journal of Clinical Investigation, 1977